These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 1964988)

  • 1. [Regulation of the remnant receptor].
    Beisiegel U
    Klin Wochenschr; 1990; 68 Suppl 22():29-31. PubMed ID: 1964988
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipoprotein receptors].
    Yamamoto T
    Tanpakushitsu Kakusan Koso; 1987 Dec; 32(13):1508-15. PubMed ID: 2832875
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
    Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
    Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the effect of lipoproteins and apoproteins on lipoprotein receptors. IV. Comparison of the physico-chemical properties of LDL between normal and hyperlipidemic rabbit serum].
    Hu YM; Xue H; Wu G; Wang KQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Jun; 7(3):182-6. PubMed ID: 3011287
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
    Chait A
    Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of apolipoproteins A to adipose cells: role of receptor sites in cholesterol efflux and purification of binding protein(s).
    Barbaras R; Puchois P; Pradines-Figuères A; Steinmetz A; Clavey V; Ghalim N; Fruchart JC; Ailhaud G
    Adv Exp Med Biol; 1991; 285():85-92. PubMed ID: 1650121
    [No Abstract]   [Full Text] [Related]  

  • 7. New low-density lipoprotein receptor upregulators acting via a novel mechanism.
    Ashton MJ; Brown TJ; Fenton G; Halley F; Harper MF; Lockey PM; Porter B; Roach AG; Stuttle KA; Vicker N; Walsh RJ
    J Med Chem; 1996 Aug; 39(17):3343-56. PubMed ID: 8765518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoprotein E].
    Xie YH; Wang KQ
    Sheng Li Ke Xue Jin Zhan; 1985 Apr; 16(2):136-41. PubMed ID: 2990024
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolism of lipoproteins: role of specific receptors].
    Mathé D; Guettet C; Lecuyer B; Jacotot B
    Journ Annu Diabetol Hotel Dieu; 1987; ():7-21. PubMed ID: 3039230
    [No Abstract]   [Full Text] [Related]  

  • 10. Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4.
    Liao W; Rudling M; Angelin B
    Hepatology; 1999 Nov; 30(5):1252-6. PubMed ID: 10534347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of LDL receptor activity in Hep-G2 cells by a serum factor(s).
    Ellsworth JL; Brown C; Cooper AD
    J Cell Physiol; 1988 May; 135(2):213-23. PubMed ID: 2836440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human lipoprotein metabolism and the liver.
    Hoeg JM; Brewer HB
    Prog Liver Dis; 1986; 8():51-64. PubMed ID: 3012641
    [No Abstract]   [Full Text] [Related]  

  • 13. Receptor pattern formation as a signal for the capture of lipoproteins.
    Mas-Oliva J; Velasco-Loyden G; Haines TH
    Biochem Biophys Res Commun; 1996 Jul; 224(1):212-8. PubMed ID: 8694814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The low density lipoprotein receptor pathway in animals and man.
    Shepherd J; Packard CJ
    Health Bull (Edinb); 1982 Jul; 40(4):197-205. PubMed ID: 6288622
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced expression of low-density lipoprotein receptor in hepatocellular carcinoma with paraneoplastic hypercholesterolemia.
    Sohda T; Iwata K; Kitamura Y; Suzuki N; Takeyama Y; Irie M; Anan A; Nakane H; Yoshikane M; Watanabe H; Sakisaka S
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e153-6. PubMed ID: 17784865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary cholesterol hypersecretion in gallstone-susceptible mice is associated with hepatic up-regulation of the high-density lipoprotein receptor SRBI.
    Fuchs M; Ivandic B; Müller O; Schalla C; Scheibner J; Bartsch P; Stange EF
    Hepatology; 2001 Jun; 33(6):1451-9. PubMed ID: 11391534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of lipid on low-density and high-density lipoprotein receptors in hepatic stellate cell from rat liver].
    Lu L; Zeng M; Li J; Hua J; Mao Y; Fan Z; Qiu D
    Zhonghua Gan Zang Bing Za Zhi; 2000 Jun; 8(3):164-6. PubMed ID: 10880167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipoprotein receptors. Old acquaintances and newcomers].
    Ducobu J
    Rev Med Brux; 1997 Feb; 18(1):10-5. PubMed ID: 9132912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.